针对癌症免疫疗法的髓状细胞:Siglec-7/9/10/15及其配体

Kelly Boelaars1, Yvette van Kooyk1

  • 1Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, De Boelelaan, 1117, Amsterdam, The Netherlands.

Trends in cancer
|December 30, 2023
PubMed
概括

瘤中的髓状细胞创造了一个免疫抑制的环境. 在这些细胞上准酸-Siglec通路为癌症免疫治疗提供了一种新的策略.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K